Raised full-year EPS guidance to greater than $3.40
Centene reported strong Q1 2026 results with EPS of $3.37, leading to a raised full-year EPS guidance of >$3.40. The company highlighted continued margin improvement in Medicaid, solid results in Medicare, and a cautious outlook for its Marketplace business amidst premium tax credit expiry, but with a promising early signal on risk adjustment. Management also emphasized progress on industry-wide data sharing (Wakely) and fraud/waste/abuse initiatives. Q1 EPS of $3.37 beat expectations by ~$0.50, driven by Medicaid and Medicare HBR outperformance.
Buzzberg 분석Raised full-year EPS guidance to greater than $3.40Centene reported strong Q1 2026 results with EPS of $3.37, leading to a raised full-year EPS guidance of >$3.40. The company highlighted continued margin improvement in Medicaid, solid results in Medicare, and a cautious outlook for its Marketplace business amidst premium tax credit expiry, but with a promising early signal on risk adjustment. Management also emphasized progress on industry-wide data sharing (Wakely) and fraud/waste/abuse initiatives. Q1 EPS of $3.37 beat expectations by ~$0.50, driven by Medicaid and Medicare HBR outperformance.전체 분석 보기분석 접기
Centene reported strong Q1 2026 results with EPS of $3.37, leading to a raised full-year EPS guidance of >$3.40. The company highlighted continued margin improvement in Medicaid, solid results in Medicare, and a cautious outlook for its Marketplace business amidst premium tax credit expiry, but with a promising early signal on risk adjustment. Management also emphasized progress on industry-wide data sharing (Wakely) and fraud/waste/abuse initiatives. Q1 EPS of $3.37 beat expectations by ~$0.50, driven by Medicaid and Medicare HBR outperformance.
Full-year 2026 EPS guidance raised to >$3.40 from >$3.00, with premium revenue increased by ~$1B due to Texas Medicaid.
Marketplace pre-tax margin guidance for 2026 embedded at ~3%, down from ~4%, pending risk adjustment visibility from June Wakely data.
Medicaid HBR improved 50bps Y/Y to 93.1% in Q1; net trend assumptions remain ~4.5% for the year.
Revenue$49.944B
+0% QoQ
EPS$3.37
reported
Gross margin21.9%
reported
Op margin3.73%
reported
이번 분기에 달라진 점
01
Guidance
Raised full-year EPS guidance to greater than $3.40
Guidance tone
02
Marketplace
Marketplace silver tier expected to receive risk adjustment offset
Q1 EPS of $3.37 beat expectations by ~$0.50, driven by Medicaid and Medicare HBR outperformance.
03
Margins
Medicaid trend outperformance driven by initiatives and lighter flu
Reported gross margin was 21.9%, reinforcing the quarter's better-than-guided profitability.
04
Medicare
Medicare Advantage on path to break-even in 2027
Marketplace pre-tax margin guidance for 2026 embedded at ~3%, down from ~4%, pending risk adjustment visibility from June Wakely data.
AI, 자본지출 및 수요 분석
AI
플랫폼 및 수익화
Management discusses deploying advanced analytics and selective AI-enabled tools across forecasting, medical economics, and payment integrity, used as an independent validation layer and to identify fraud, waste, and abnormal claims behavior earlier.
수요
수주 및 전환
Management raised full-year EPS guidance citing better-than-expected Q1 results across Medicaid and Medicare, momentum in margin improvement initiatives and increased visibility, while maintaining a cautious stance on the balance of the year.
톤 · Confident
Management expresses confidence in operational improvements and margin recovery, citing strong Q1 results and positive momentum across all segments.
공급망 알파
A1
Centene is leveraging a new industry-wide data sharing initiative (Wakely March report) to gain earlier visibility into ACA risk pool dynamics, confirming a shift toward higher-acuity silver members and validating expectations of a meaningful risk adjustment receivable.
“the industry has more visibility than it has ever had at this time of the year about overall market dynamics.”
Centene notes that 2027 Medicare Advantage final rates improved versus the advance notice but remain below medical cost trend; the company also highlights a model mechanic that will push Part D direct subsidy up significantly again in 2027.
“this, coupled with the mere mechanic of a risk model that's calibrated based upon pre-IRA claims data... should push the direct subsidy up quite a bit again in 2027.”
Centene reports that its fraud, waste, and abuse (FWA) programs, particularly in ABA therapy, are yielding results, showing stabilizing year-over-year trends and the identification of outlier providers with 'suspect or fraudulent billing patterns'.
“we are seeing stabilizing year-over-year ABA trends that we believe are a direct result of the actions we have taken to ensure appropriate high-quality care for ABA members”